Samir M Hanash

Title: Innovations in Cancer Screening by Samir M Hanash

Introduction

Samir M Hanash is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer diagnostics through his innovative research and inventions. With a total of 8 patents, Hanash has focused on developing methods that enhance the early detection and prognosis of cancer.

Latest Patents

One of Hanash's latest patents involves the use of annexin proteins and autoantibodies as serum markers for cancer. This invention relates to screening methods for diagnosing, prognosing, or assessing susceptibility to cancer in subjects. The method detects the presence of serum autoantibodies to specific annexin protein antigens in sera from subjects. Additionally, it provides screening methods for diagnosing and prognosing cancer by detecting increased expression levels of annexin proteins in biological samples. This innovative approach can identify subjects at risk for developing cancer and involves using subject-derived biological samples to determine the occurrence and level of expression of annexin proteins or their derived peptides or antigens. Furthermore, the invention includes kits designed for these screening methods, which can be utilized as diagnostic, predictive, or prognostic indicators of cancer.

Career Highlights

Samir M Hanash is affiliated with the University of Michigan, where he continues to advance his research in cancer diagnostics. His work has garnered attention for its potential to improve cancer detection and patient outcomes.

Collaborations

Hanash has collaborated with notable colleagues, including David Misek and Robert Hinderer, to further enhance the impact of his research in the field of cancer diagnostics.

Conclusion

Samir M Hanash's innovative contributions to cancer screening exemplify the importance of research in improving diagnostic methods. His work continues to pave the way for advancements in early cancer detection and patient care.